Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03KQG
|
|||
| Former ID |
DNC012069
|
|||
| Drug Name |
Pyrrolidin-1-yl-thiourea
|
|||
| Synonyms |
CHEMBL48338; 88147-87-9; N-Pyrrolidin-1-ylthiourea; Thiourea, 1-pyrrolidinyl-; SCHEMBL5320211; CTK3B7005; DTXSID20658163
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C5H11N3S
|
|||
| Canonical SMILES |
C1CCN(C1)NC(=S)N
|
|||
| InChI |
1S/C5H11N3S/c6-5(9)7-8-3-1-2-4-8/h1-4H2,(H3,6,7,9)
|
|||
| InChIKey |
LUZJFNYVKQEEGM-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 88147-87-9
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Transient receptor potential cation channel V1 (TRPV1) | Target Info | Inhibitor | [1] |
| Transient receptor potential cation channel V4 (TRPV4) | Target Info | Inhibitor | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Inflammatory mediator regulation of TRP channels | ||||
| NetPath Pathway | IL2 Signaling Pathway | |||
| Pathway Interaction Database | Trk receptor signaling mediated by the MAPK pathway | |||
| Trk receptor signaling mediated by PI3K and PLC-gamma | ||||
| Reactome | TRP channels | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | N-4-methansulfonamidobenzyl-N'-2-substituted-4-tert-butyl-benzyl thioureas as potent vanilloid receptor antagonistic ligands. Bioorg Med Chem Lett. 2004 Apr 5;14(7):1693-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.